Recent News

By Category: Research

Effect of Experimental Ebola Vaccine after High-Risk Exposure

A study appearing this week in JAMA analyzes the case of a 44-year-old U.S. physician who received an experimental Ebola vaccine after experiencing a needle stick while working in an Ebola treatment unit in Sierra Leone.

UC Davis Working to Help Speed Ebola Drug Production

Researchers at the University of California, Davis will explore ways to speed production of the Ebola drug with a $200,000 rapid-response grant from the National Science Foundation. Developed by Mapp Biopharmaceutical Inc. of San Diego, in collaboration with the U.S. government and partners in Canada, Zmapp is a cocktail of antibodies produced in and extracted  Read More »

Possible Game-Changing Antibiotics from Soil Bacterium

Researchers have found a potential drug to fight the evolving antibiotic crisis, buried just underfoot in the soil in Maine. Named teixobactin, the promising target was discovered by a team led by Kim Lewis of Northeastern University, and has proven effective at killing methicillin-resistant Staphylococcus aureus (MRSA) and Mycobacterium tuberculosis in mice, and a host  Read More »

New 15-Minute Ebola Diagnostic to be Trialed in Guinea

A rapid, point-of-care diagnostic test for the Ebola virus will be trialed in the coming weeks at the Ebola treatment center in Conakry, Guinea

NIAID/GSK Experimental Ebola Vaccine Appears Safe

Results from a National Institutes of Health (NIH) Phase 1 clinical trial support accelerated development of the candidate vaccine to prevent Ebola virus disease.